Mayo Clinic study: Tranexamic acid reduces risk of liver failure after surgery by threefold
By
Chloe Corey
Summary
A multi-center study co-led by Mayo Clinic and Michigan State University found that tranexamic acid given during liver surgery reduces the risk of post-hepatectomy liver failure by three times compared to placebo. This complication is a leading cause of death after liver resection, and currently no approved medications exist to prevent it. The findings were published in Blood.
Source
Twitter / XMayo Clinic study: Tranexamic acid reduces risk of liver failure after surgery by threefoldmayocl.inKey quotes
· 1 pulledDr. Patrick Starlinger performing surgery.
You might also wanna read
Pharmabiotics, Phocaeicola dorei, ameliorates cholestatic liver fibrosis by alleviating macrophage efferocytosis of neutrophils
Herbal and dietary supplements linked to increasing cases of liver injury
This article discusses the growing concern of liver injury (hepatotoxicity) caused by herbal and dietary supplements (HDS). It highlights th
journals.lww.com·5d ago
Third Death in Sarepta Gene Therapy Trial for Limb-Girdle Muscular Dystrophy
A 51-year-old patient in a Phase I study of Sarepta's gene therapy for Limb-Girdle muscular dystrophy Type 2E has died from acute liver toxi
biocentury.com·11mo agoHepatic SNHG9 links gut microbiota to liver protection in drug-induced liver injury
Microbial metabolite restores liver health by targeting PPARα and lipid metabolism through the gut-liver axis
This scientific research article reports on the therapeutic potential of a microbial metabolite (10-hydroxy-10-hydr) in alleviating liver in
journals.asm.org·10mo ago
New blood test uses machine learning to detect early liver scarring that can lead to cancer
A new blood test in development uses machine learning to analyze free-floating DNA in the blood to detect early-stage liver scarring (fibros
livescience.com·14h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.